COVID-19

The analyser is part of an assessment of the AI-based ‘CURIAL’ test to screen for COVID-19 in patients.

Value-based care implies radical, even disruptive changes to the current practice, say Paulus Torkki, associate professor of healthcare operations management at University of Helsinki and Marianna Imenokhoeva, founder of LinktoMedicine and HIMSS Future50 Leader. 

Study finds nasal spray delivery offers "many benefits" over traditional approaches to vaccine administration.

The system delivers its results to a companion app in about 20 minutes, according to the agency.

Deprexis, an app used to help mental health, is the 11th app to be approved for medical prescription and reimbursement in Germany so far via DiGA, and MobiHealthNews learns more about the process from Julia Hagen, Health Innovation Hub.

In collaboration with Affinidi, a global investment firm headquartered in Singapore, Malaysia’s Immunitee Health Passport will become the country’s first health passport allowing tourists to be accepted into Singapore upon being verified and cleared via the Affinidi’s Unifier digital credential platform.

J.P. Morgan's Stuart Hanson outlines three strategies for organizations looking to keep pace with digital transformation spurred by COVID-19.

Respiray’s wearable device allegedly kills over 99% of viruses and bacteria with UV light and filter.

The smartphone-enabled LooK SPOT test scans for nucleocapsid protein from SARS-CoV-2 in nasal swabs, with results reportedly available in five to eight minutes.

Also: The Consumer Technology Association releases industry standards focused on health AI trust; new updates in the home COVID-19 testing market.